Statement
1 Feb 2023
Substandard and falsified medical products (EB152)
On 1 February 2023, IPSF submitted a statement delivered on behalf of IPSF, IAPO, and IFPMA for the WHO EB152 agenda item related to substandard and falsified medical products.
Read more
Statement
10 Jun 2021
IFPMA and local pharmaceutical industry associations call on the African and global health communities to raise awareness about the dangers of substandard and falsified medical products
On World Anti-counterfeit day, 10 June 2021, the IFPMA hosted a joint event with local Pharmaceutical Industry Associations from across the African continent to tackle the topic of falsified medicines and chart a robust response to eliminate falsified medicines in the region.
Read more
Statement
10 Jun 2021
R&D bio-pharmaceutical groups warn about rise in COVID-19 falsified medical products in Africa and call governments to ratify the Medicrime Convention to crack down on illicit activities
The COVID-19 pandemic has led to a global surge in reported falsified medical products including personal protective equipment, diagnostic tests, and more recently falsified or substandard medicines, “cures” and vaccines.
Read more
